title: [Treatment of fibrocystic breast disease with danazol. A multicenter study].
authors.forename: P
authors.initials: P
authors.lastname: Fioretti
authors.forename: A M
authors.initials: AM
authors.lastname: Paoletti
authors.forename: F D
authors.initials: FD
authors.lastname: Petacchi
authors.forename: R
authors.initials: R
authors.lastname: Prato
authors.forename: G A
authors.initials: GA
authors.lastname: Mauro
authors.forename: G B
authors.initials: GB
authors.lastname: Melis
mesh_terms: D000328:Adult; D000368:Aged; D003613:Danazol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005348:Fibrocystic Breast Disease / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011245:Pregnadienes / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D011245:Pregnadienes; D003613:Danazol
vernacular_title: Trattamento della mastopatia fibrocistica con danazolo. Studio multicentrico.